SOAT1 and neoplasm: While antibody blocking of inhibitory ligands or STAT inhibitors has been shown to be effective at enhancing NK cell lysis of tumor cells, these modalities have some potential limitations, including off-target effects on non-cancerous cells and the activation of other immune cells.